Teriflunomide Delays MS Symptoms in RIS
For patients with radiologically isolated syndrome (RIS) predictive of multiple sclerosis (MS), teriflunomide reduced the risk of a demyelinating event over a 2-year period in a phase 3 trial.
Stay updated with breaking news from Ms Risk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For patients with radiologically isolated syndrome (RIS) predictive of multiple sclerosis (MS), teriflunomide reduced the risk of a demyelinating event over a 2-year period in a phase 3 trial.
Catching MS cases earlier in children could provide a different treatment trajectory, but early clues are often overlooked.
Experts are leading an initiative to drive home the message that clinicians must consider MS in the differential diagnosis for Black patients and others who present with symptoms of demyelination.
Poor sleep quality or sleeping less than 7 hours a night during adolescence is linked to a 40% to 50% increase in risk for multiple sclerosis as an adult, new research shows.
An expert panel has proposed a new framework for the diagnosis and treatment of multiple sclerosis to replace the current subtype classifications, based on disease progression.